 | • レポートコード：D0GIR-02956 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん輸液療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。がん輸液療法の種類別市場規模（薬局、在宅医療機関、その他）、用途別市場規模（がん、慢性疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Option Care Health、PharMerica、HCA Healthcare、Coram CVS、Accredo Health、UnitedHealth Group、CHI Health、McLaren ・地域別グローバル市場分析 2015年-2020年 ・がん輸液療法の北米市場（アメリカ、カナダ、メキシコ） ・がん輸液療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん輸液療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん輸液療法の南米市場（ブラジル、アルゼンチン） ・がん輸液療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：薬局、在宅医療機関、その他 ・用途別分析：がん、慢性疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Cancer Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Cancer Infusion Therapy sales will be xx in 2020 from Cancer Infusion Therapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Cancer Infusion Therapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Cancer Infusion Therapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Cancer Infusion Therapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Cancer Infusion Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Infusion Therapy market has been segmented into:
Pharmacies
Home Health Agencies
Others
By Application, Cancer Infusion Therapy has been segmented into:
Cancer
Chronic Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Infusion Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Infusion Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Infusion Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Infusion Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Infusion Therapy Market Share Analysis
Cancer Infusion Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Infusion Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Infusion Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Infusion Therapy are:
Option Care Health
PharMerica
HCA Healthcare
Coram CVS
Accredo Health
UnitedHealth Group
CHI Health
McLaren
Among other players domestic and global, Cancer Infusion Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Cancer Infusion Therapy Market Overview
1.1 Product Overview and Scope of Cancer Infusion Therapy
1.2 Classification of Cancer Infusion Therapy by Type
1.2.1 Global Cancer Infusion Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Infusion Therapy Revenue Market Share by Type in 2019
1.2.3 Pharmacies
1.2.4 Home Health Agencies
1.2.5 Others
1.3 Global Cancer Infusion Therapy Market by Application
1.3.1 Overview: Global Cancer Infusion Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Chronic Disease
1.3.4 Others
1.4 Global Cancer Infusion Therapy Market by Regions
1.4.1 Global Cancer Infusion Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Infusion Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Infusion Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Infusion Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Infusion Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Infusion Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Infusion Therapy Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Cancer Infusion Therapy Industry Impact
1.5.1 COVID-19 Potential Implications for the Cancer Infusion Therapy
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Cancer Infusion Therapy
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Option Care Health
2.1.1 Option Care Health Details
2.1.2 Option Care Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Option Care Health SWOT Analysis
2.1.4 Option Care Health Product and Services
2.1.5 Option Care Health Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 PharMerica
2.2.1 PharMerica Details
2.2.2 PharMerica Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 PharMerica SWOT Analysis
2.2.4 PharMerica Product and Services
2.2.5 PharMerica Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 HCA Healthcare
2.3.1 HCA Healthcare Details
2.3.2 HCA Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 HCA Healthcare SWOT Analysis
2.3.4 HCA Healthcare Product and Services
2.3.5 HCA Healthcare Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Coram CVS
2.4.1 Coram CVS Details
2.4.2 Coram CVS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Coram CVS SWOT Analysis
2.4.4 Coram CVS Product and Services
2.4.5 Coram CVS Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Accredo Health
2.5.1 Accredo Health Details
2.5.2 Accredo Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Accredo Health SWOT Analysis
2.5.4 Accredo Health Product and Services
2.5.5 Accredo Health Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 UnitedHealth Group
2.6.1 UnitedHealth Group Details
2.6.2 UnitedHealth Group Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UnitedHealth Group Product and Services
2.6.4 UnitedHealth Group Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 CHI Health
2.7.1 CHI Health Details
2.7.2 CHI Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CHI Health Product and Services
2.7.4 CHI Health Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 McLaren
2.8.1 McLaren Details
2.8.2 McLaren Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 McLaren Product and Services
2.8.4 McLaren Cancer Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Infusion Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Infusion Therapy Players Market Share
3.2.2 Top 10 Cancer Infusion Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Infusion Therapy Revenue and Market Share by Regions
4.2 North America Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
5 North America Cancer Infusion Therapy Revenue by Countries
5.1 North America Cancer Infusion Therapy Revenue by Countries (2015-2020)
5.2 USA Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
6 Europe Cancer Infusion Therapy Revenue by Countries
6.1 Europe Cancer Infusion Therapy Revenue by Countries (2015-2020)
6.2 Germany Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
6.4 France Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Infusion Therapy Revenue by Countries
7.1 Asia-Pacific Cancer Infusion Therapy Revenue by Countries (2015-2020)
7.2 China Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
7.5 India Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
8 South America Cancer Infusion Therapy Revenue by Countries
8.1 South America Cancer Infusion Therapy Revenue by Countries (2015-2020)
8.2 Brazil Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Infusion Therapy by Countries
9.1 Middle East & Africa Cancer Infusion Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Infusion Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Infusion Therapy Market Forecast by Type (2019-2024)
10.3 Pharmacies Revenue Growth Rate (2015-2025)
10.4 Home Health Agencies Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Cancer Infusion Therapy Market Segment by Application
11.1 Global Cancer Infusion Therapy Revenue Market Share by Application (2015-2020)
11.2 Cancer Infusion Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Chronic Disease Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Cancer Infusion Therapy Market Size Forecast (2021-2025)
12.1 Global Cancer Infusion Therapy Market Size Forecast (2021-2025)
12.2 Global Cancer Infusion Therapy Market Forecast by Regions (2021-2025)
12.3 North America Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
12.6 South America Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Infusion Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Infusion Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Infusion Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Infusion Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Cancer Infusion Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Option Care Health Corporate Information, Location and Competitors
Table 7. Option Care Health Cancer Infusion Therapy Major Business
Table 8. Option Care Health Cancer Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Option Care Health SWOT Analysis
Table 10. Option Care Health Cancer Infusion Therapy Product and Solutions
Table 11. Option Care Health Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. PharMerica Corporate Information, Location and Competitors
Table 13. PharMerica Cancer Infusion Therapy Major Business
Table 14. PharMerica Cancer Infusion Therapy Total Revenue (USD Million) (2018-2019)
Table 15. PharMerica SWOT Analysis
Table 16. PharMerica Cancer Infusion Therapy Product and Solutions
Table 17. PharMerica Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. HCA Healthcare Corporate Information, Location and Competitors
Table 19. HCA Healthcare Cancer Infusion Therapy Major Business
Table 20. HCA Healthcare Cancer Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 21. HCA Healthcare SWOT Analysis
Table 22. HCA Healthcare Cancer Infusion Therapy Product and Solutions
Table 23. HCA Healthcare Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Coram CVS Corporate Information, Location and Competitors
Table 25. Coram CVS Cancer Infusion Therapy Major Business
Table 26. Coram CVS Cancer Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Coram CVS SWOT Analysis
Table 28. Coram CVS Cancer Infusion Therapy Product and Solutions
Table 29. Coram CVS Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Accredo Health Corporate Information, Location and Competitors
Table 31. Accredo Health Cancer Infusion Therapy Major Business
Table 32. Accredo Health Cancer Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Accredo Health SWOT Analysis
Table 34. Accredo Health Cancer Infusion Therapy Product and Solutions
Table 35. Accredo Health Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. UnitedHealth Group Corporate Information, Location and Competitors
Table 37. UnitedHealth Group Cancer Infusion Therapy Major Business
Table 38. UnitedHealth Group Cancer Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 39. UnitedHealth Group SWOT Analysis
Table 40. UnitedHealth Group Cancer Infusion Therapy Product and Solutions
Table 41. UnitedHealth Group Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. CHI Health Corporate Information, Location and Competitors
Table 43. CHI Health Cancer Infusion Therapy Major Business
Table 44. CHI Health Cancer Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 45. CHI Health SWOT Analysis
Table 46. CHI Health Cancer Infusion Therapy Product and Solutions
Table 47. CHI Health Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. McLaren Corporate Information, Location and Competitors
Table 49. McLaren Cancer Infusion Therapy Major Business
Table 50. McLaren Cancer Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 51. McLaren SWOT Analysis
Table 52. McLaren Cancer Infusion Therapy Product and Solutions
Table 53. McLaren Cancer Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Cancer Infusion Therapy Revenue (Million USD) by Players (2015-2020)
Table 55. Global Cancer Infusion Therapy Revenue Share by Players (2015-2020)
Table 56. Global Cancer Infusion Therapy Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Cancer Infusion Therapy Revenue Market Share by Regions (2015-2020)
Table 58. North America Cancer Infusion Therapy Revenue by Countries (2015-2020)
Table 59. North America Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 60. Europe Cancer Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Cancer Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Cancer Infusion Therapy Revenue by Countries (2015-2020)
Table 63. South America Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Cancer Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 66. Global Cancer Infusion Therapy Revenue (Million USD) by Type (2015-2020)
Table 67. Global Cancer Infusion Therapy Revenue Share by Type (2015-2020)
Table 68. Global Cancer Infusion Therapy Revenue Forecast by Type (2021-2025)
Table 69. Global Cancer Infusion Therapy Revenue by Application (2015-2020)
Table 70. Global Cancer Infusion Therapy Revenue Share by Application (2015-2020)
Table 71. Global Cancer Infusion Therapy Revenue Forecast by Application (2021-2025)
Table 72. Global Cancer Infusion Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Infusion Therapy Picture
Figure 2. Global Cancer Infusion Therapy Revenue Market Share by Type in 2019
Figure 3. Pharmacies Picture
Figure 4. Home Health Agencies Picture
Figure 5. Others Picture
Figure 6. Cancer Infusion Therapy Revenue Market Share by Application in 2019
Figure 7. Cancer Picture
Figure 8. Chronic Disease Picture
Figure 9. Others Picture
Figure 10. Global Cancer Infusion Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Cancer Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Cancer Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Cancer Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Cancer Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Cancer Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Cancer Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cancer Infusion Therapy Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Cancer Infusion Therapy Revenue Market Share in 2019
Figure 19. Global Top 10 Players Cancer Infusion Therapy Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Cancer Infusion Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Cancer Infusion Therapy Revenue Market Share by Regions (2015-2020)
Figure 23. Global Cancer Infusion Therapy Revenue Market Share by Regions in 2018
Figure 24. North America Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Europe Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 27. South America Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 29. North America Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 30. North America Cancer Infusion Therapy Revenue Market Share by Countries in 2019
Figure 31. USA Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Canada Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Europe Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Cancer Infusion Therapy Revenue Market Share by Countries in 2019
Figure 36. Germany Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 37. UK Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 38. France Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Russia Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Italy Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Cancer Infusion Therapy Revenue Market Share by Countries in 2019
Figure 43. China Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Japan Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Korea Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 46. India Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 48. South America Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 49. South America Cancer Infusion Therapy Revenue Market Share by Countries in 2019
Figure 50. Brazil Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Cancer Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Cancer Infusion Therapy Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 55. UAE Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Cancer Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Global Cancer Infusion Therapy Revenue Share by Type (2015-2020)
Figure 59. Global Cancer Infusion Therapy Revenue Share by Type in 2019
Figure 60. Global Cancer Infusion Therapy Market Share Forecast by Type (2021-2025)
Figure 61. Global Pharmacies Revenue Growth Rate (2015-2020)
Figure 62. Global Home Health Agencies Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Cancer Infusion Therapy Revenue Share by Application (2015-2020)
Figure 65. Global Cancer Infusion Therapy Revenue Share by Application in 2019
Figure 66. Global Cancer Infusion Therapy Market Share Forecast by Application (2021-2025)
Figure 67. Global Cancer Revenue Growth Rate (2015-2020)
Figure 68. Global Chronic Disease Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Cancer Infusion Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Cancer Infusion Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Cancer Infusion Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 74. Europe Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 76. South America Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Cancer Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
代替部位注入療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Alternate-site Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 外来輸液療法サービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Outpatient Infusion Therapy Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 家庭用輸液療法デバイスの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Home Infusion Therapy Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 22150 million by 2025, from USD 19050 million in 2019. The Home Inf…
- 外来輸液療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Ambulatory Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 外来点滴センターの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Ambulatory Infusion Center market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…